IL17A and diabetes mellitus: Diabetic mice have increased IL-17, and iNOS expression, inflammatory macrophage and slower wound healing.[20] Diabetes-enhanced IL-17 induces increased neutrophil recruitment, IL-6 and RANKL, and bone resorption, making them more pathogenic.[21]